Plasma membrane assays and three-compartment image cytometry for high content screening

Assay and Drug Development Technologies

Volumn 5, Issue 1, 2007, Pages 29-48

  Prigozhina, Natalie L ^a,c   Zhong, Ling ^d   Hunter, Edward A ^a,b   Mikić, Ivana ^a,b   Callaway, Scott ^a,b   Roop, Dennis R ^d   Mancini, Michael A ^d   Zacharias, David A ^e   Price, Jeffrey H ^a,c   McDonough, Patrick M ^a  

^a VALA SCIENCES INC   (United States)

^b Hunter Miki and Callaway   (United States)

^c BURNHAM INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL PROTEIN; NERVE CELL ADHESION MOLECULE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ALPHA; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN;

ALGORITHM; ARTICLE; CELL ADHESION; CELL DIVISION; CELL MEMBRANE; CELL MIGRATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOMETRY; DIGITAL IMAGING; DNA CONTENT; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MICROPHOTOGRAPHY; NONHUMAN; SKIN CANCER; VALIDATION PROCESS;

BIOLOGICAL ASSAY; CELL MEMBRANE; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE, MULTIPHOTON;

EID: 34147203099     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.024     Document Type: Article

References (57)

1. Morelock M, Hunter E, Moran T, Heynen S, Laris C, Thieleking M, et al.: Statistics of assay validation in high throughput cell imaging of nuclear factor κB nuclear translocation. Assay Drug Dev Technol 2005;3:483-499.
2. Ding G, Fischer P, Boltz R, Schmidt J, Colaianne J, Gough A, et al.: Characterization and quantitation of NFκB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α. J Biol Chem 1998;273:28897-28905.
3. Wilson C, Si Y, Thompsons C, Smellie A, Ashwell M, Liu J-F, et al.: Identification of a small molecule that induces mitotic arrest using a simplified high-content screening assay and data analysis method. J Biomol Screen 2006;11:21-28.
4. Harada J, Bower K, Orth A, Callaway S, Nelson C, Laris C, et al.: Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis. Genome Res 2005;15:1136-1144.
5. Cho C, Koo S-H, Wang Y, Callaway S, Hedrick S, Mak P, et al.: Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling. Cell Metab 2006;3:367-378.
6. Granas C, Lundholt B, Loechel F, Pedersen H-C, Bjorn S, Linde V, et al.: Identification of RAS-mitogen-activated protein kinase signaling pathway modulators in an ERF1 redistribution screen. J Biomol Screen 2006;11:423-434.
7. Moffat J, Grueneberg D, Yang X, Kim S, Kloepfer A, Hinkle G, et al.: A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006;124:1283-1298.
8. Neumann B, Held M, Liebel U, Erfle H, Rogers P, Pepperkok R, et al.: High-throughput RNAi screening by time-lapse imaging of live human cells. Nat Methods 2006;3:385-390.
9. Bertelsen M, Sanfridson A: Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev Technol 2005;3:261-271.
10. Lundholt BK, Linde V, Loechel F, Pedersen H, Moller S, Praestegaard M, et al.: Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 Analyzer. J Biomol Screen 2005;10:20-29.
11. Almholt K, Arkhammar P, Thastrup O, Tullin S: Simultaneous visualization of the translocation of protein kinase C alpha-green fluorescent protein hybrids and intracellular calcium concentrations. Biochem J 1999;337:211-218.
12. Granas C, Lundholt B, Heydorn A, Linde V, Pedersen H, Krog-Jensen C, et al.: High content screening for G protein-coupled receptors using cell-based protein translocation assays. Comb Chem High Throughput Screen 2005;8:301-309.
13. Mikic I, Planey S, Zhang J, Ceballos C, Seron T, Von Massenbach B, et al.: A live cell, image-based approach to understanding the enzymology and pharmacology of 2-bromopalmitate and palmitoylation. Methods Enzymol 2006;414:150-187.
14. Michie M, Nakagawa R: The link between PKCα regulation and cellular transformation. Immunol Lett 2005;96:155-162.
15. Radeff J, Tingh A, Stern P: Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase C α and interleukin-6 in UMR-106 osteoblastic cells. Cell Signal 2004;16:105-114.
16. Walker J, Fournier A, Assoian R: Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension. Cytokine Growth Factor Rev 2005;16:395-405.
17. Daniels D, Spink K, Weis W: β-Catenin: molecular plasticity and drug design. Trends Biochem Sci 2001;26:672-678.
18. Cavallaro U: N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 2004;5:1274-1278.
19. Vincent P, Xiao K, Buckley K, Kowalczyk A: VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol 2004;286:C987-C997.
20. Caveda L, Martin-Padura I, Navarro P, Breviario F, Corada M, Gulino D, et al.: Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE- cadherin). J Clin Invest 1996;98:886-893.
21. Martin-Padura I, De C, Uccini S, Pilozzi E, Natali P, Nicotra M, et al.: Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 1995;175:51-57.
22. Hendrix M, Seftor E, Meltzer P, Gardner L, Hess A, Kirschmann D, et al.: Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A 2001;98:8018-8023.
23. Weis S, Cui J, Barnes L, Cheresh D: Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004;167:223-229.
24. Nair K, Naidoo R, Cherry R: Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 2005;58:343-351.
25. Garcea G, Neal C, Pattenden C, Steward W, Berry D: Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005;41:2213-2236.
26. Dey P: Aneuploidy and malignancy: an unsolved equation. J Clin Pathol 2004;57:1245-1249.
27. Kops G, Weaver B, Cleveland D: On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-785.
28. Calkins C, Hoepner B, Law C, Novak M, Setzer S, Hatzfeld M, et al.: The Armadillo family protein p0071 is a VE-cadherin- and desmoplakin-binding protein. J Biol Chem 2003;278:1774-1783.
29. Caulin C, Nguyen T, Longley M, Zhou Z, Wang X, Roop D: Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res 2004;64:5054-5058.
30. Koster M, Lu S, White L, Wang X, Roop D: Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. Cancer Res 2006;66:3981-3986.
31. Roop D, Cheng C, Titterington L, Meyers C, Stanley J, Steinert P, et al.: Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 1984;259:8037-8040.
32. Hunter E, McDonough P, Mikic I, Price J: System, method and kit for processing a magnified image of biological material to identify components of a biological object. U.S. Patent Application 11/285,691. Filed November 21, 2005.
33. Zhang J, Chung T, Oldenburg K: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
34. Rosenberger U, Lehmann I, Weise C, Franke P, Hucho F, Buchner K: Identification of PCF as a protein kinase Calpha-binding protein in the cell nucleus. J Cell Biochem 2002;86:394-402.
35. Denk C, Hulsken J, Schwarz E: Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett 1997;120:185-193.
36. Wahl J: A role for plakophilin-1 in the initiation of desmosome assembly. J Cell Biochem 2005;96:390-403.
37. Delannoy P, Lemonnier J, Hay E, Modrowski D, Marie P: Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts. Exp Cell Res 2001;269:154-161.
38. Okamoto R, Irie K, Yamada A, Katata T, Fukuhara A, Takai Y: Recruitment of E-cadherin associated with alpha-and beta-catenins and p120ctn to the nectin-based cell-cell adhesion sites by the action of 12-O- tetradecanoylphorbol-13-acetate in MDCK cells. Genes Cells 2005;10:435-445.
39. Schnittler H, Pushel B, Drenckhahn D: Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and shear stress. Am J Physiol 1997;273:H2396-H2405.
40. Otero K, Martinez F, Beltran A, Gonzalez D, Herrera B, Quintero G, et al.: Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 2001;359:567-574.
41. Geiger B, Volberg T, Ginsberg D, Bitzur S, Sabanay I, Hynes R: Broad spectrum pan- cadherin antibodies, reactive with the C-terminal 24 amino acid residues of N-cadherin. J Cell Sci 1990;97:607-614.
42. Rajagopalan H, Lengauer C: Aneuploidy and cancer. Nature 2004;431:338-341.
43. Yang C, Kazanietz M: Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol Sci 2003;24:602-608.
44. Lewis J, Jensen P, Johnson K, Wheelock M: E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 1995;108:3615-1621.
45. Barbosa L, Goto-Silva L, Redondo P, Oliveira S, Montesano G, de Souza W, et al.: TPA-induced signal transduction: a link between PKC and EGFR signaling modulates the assembly of intercellular junctions in Caco-2 cells. Cell Tissue Res 2003;312:319-331.
46. Fabre M, Garcia de Herreros A: Phorbol ester-induced scattering of HT-29 human intestinal cancer cells is associated with down-modulation of E-cadherin. J Cell Sci 1993;106:513-522.
47. Wen-Sheng W, Jun-Ming H: Activation of protein kinase C alpha is required for TPA- triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2. J Biomed Sci 2005;12:289-296.
48. Wu J, Sheibani N: Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases. J Cell Biochem 2003;90:121-137.
49. Nwariaku F, Chang J, Zhu X, Liu Z, Duffy S, Halaihel N, et al.: The role of p38 MAP kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock 2002;18:82-85.
50. Kononen J, Bubendorf L, Kallioniemi A: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847.
51. Skacel M, Skilton B, Pettay J, Tubbs R: Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens. Appl Immunohistochem Mol Morphol 2002;10:1-6.
52. Camp RL, Charette LA, Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-1949.
53. Zhang D, Salto-Tellez M, Putti T, Do E, Koay E: Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 2003;16:79-84.
54. Rubin M, Dunn R, Strawderman M, Pienta K: Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312-319.
55. Rabinovich A, Krajewski S, Krajewska M, Shabaik A, Hewitt S, Belongie S, et al.: Framework for parsing, visualizing and scoring tissue microarray images. IEEE Trans Inform Technol Biomed 2006;10:209-291.
56. Huang Q, Yu C, Klein M, Fang J, Goyal R: DNA index determination with automated cellular imaging system (ACIS) in Barrett's esophagus: comparison with CAS 200. BMC Clin Pathol 2005;5:7.
57. Wohlrab D, Klapperstuck T, Holzhausen H, Held A, Hein W: DNA image cytometry on sections compared with flow cytometry in human bone metastases. Oncol Rep 2005;14:1005-1012.